Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

Dr. Ergin's SugarMD Advanced Glucose Support Recalled for Drug Tainting

Agency Publication Date: December 2, 2023
Share:
Sign in to monitor this recall

Summary

SugarMDs LLC is recalling 32,117 units of Dr. Ergin's SugarMD Advanced Glucose Support Capsules because the product was found to be tainted with metformin and glyburide, which are prescription drugs used to treat type 2 diabetes. The recall affects 60-count, 120-count, and 180-count bottles that were sold nationwide across the United States and through various online websites. Because this product contains undeclared prescription drugs, it is being marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

Risk

Metformin and glyburide are potent diabetes medications that can cause blood sugar levels to drop dangerously low, a condition known as hypoglycemia. This risk is significantly increased if a consumer is already taking other diabetes medications, potentially leading to seizures, loss of consciousness, or life-threatening complications.

What You Should Do

  1. This recall affects Dr. Ergin's SugarMD Advanced Glucose Support Capsules sold in 60-count bottles (UPC 195893927678), 120-count bottles (UPC 195893546978), and 180-count bottles (UPC 195893999576). Affected containers are marked with Lot # 22165-003 and an expiration date of 09/30/2024.
  2. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  3. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

💰Option 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
🗑️Option 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Dr. Ergin's SugarMD Advanced Glucose Support Capsules
Variants: 60 count, 120 count, 180 count
UPC Codes:
195893927678
195893546978
195893999576
Lot Numbers:
22165-003 (Exp 09/30/2024)

Product found to be tainted with metformin and glyburide.

Product Images

“Dr. Ergin’s SugarMD Advanced Glucose Support, Dietary Supplement, 120 capsules”

“Dr. Ergin’s SugarMD Advanced Glucose Support, Dietary Supplement, 120 capsules”

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93394
Status: Active
Manufacturer: SUGARMDS LLC
Sold By: online websites
Manufactured In: United States
Units Affected: 32,117
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release (1) · FDA Press Release (2) · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.